Wordt geladen...
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
INTRODUCTION: Natalizumab is a new treatment for relapsing-remitting multiple sclerosis. Because of limited experience of this treatment, medical professionals must be alert to possible side effects. CASE PRESENTATION: We present a 34-year-old Caucasian woman with relapsing-remitting multiple sclero...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2827173/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4076/1752-1947-3-8955 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|